Funding for this research was provided by:
Capital's Funds for Health Improvement and Research (ShouFa 2018-1-4061)
National Natural Science Foundation of China (81904001)
Received: 23 July 2019
Accepted: 24 March 2020
First Online: 1 May 2020
Ethics approval and consent to participate
: This study was approved by the ethics committees of five centers, including China-Japan Friendship Hospital (2018–82-K57), Beijing Friendship Hospital Affiliated to Capital Medical University (2019-P2–016-02), Beijing Hospital of TCM Affiliated to Capital Medical University (2018BL-057-02), Wangjing Hospital of China Academy of Traditional Chinese Medicine (WJEC-KT-2018-045-P001), and Beijing Chaoyang Hospital Affiliated to Capital Medical University (2018-KE-313). This trial has been registered with ChiCTR1800018490. The trial will be performed according to the Declaration of Helsinki and Good Clinical Practice (GCP) described by the China Food and Drug Administration. The investigators will provide the explanations about this study to all participants in the screening period. The eligible subject will sign the informed consent form prior to enrollment. Throughout and subsequent to the trial, the personal privacy information and test data of each subject will remain secret.
: Not applicable.
: The authors declare that they have no competing interests.